Related by context. All words. (Click for frequent words.) 69 Bevacizumab 68 Pemetrexed 68 Vandetanib 68 Dasatinib 68 biologic therapy 68 Alemtuzumab 67 Ofatumumab 67 Rituximab 67 Erlotinib 67 Lenalidomide 67 indolent NHL 67 Advexin 67 Sorafenib 66 YONDELIS 66 Everolimus 66 Amrubicin 66 Tasigna nilotinib 66 Avastin bevacizumab 66 Gemcitabine 65 Adalimumab 65 Epratuzumab 65 Ceflatonin 65 Hycamtin 65 Treanda 65 Elesclomol 65 Dapagliflozin 65 bevacizumab Avastin 65 Noxafil 65 Revlimid lenalidomide 65 Pazopanib 65 Perifosine 65 Golimumab 65 Nexavar ® 65 Onco TCS 65 axitinib 65 TEMODAL 65 Rituxan rituximab 65 vandetanib 65 BAY #-# 65 Pirfenidone 65 Pertuzumab 65 CHOP chemotherapy 65 Torisel 65 Irinotecan 65 Firazyr 65 Interferon beta 1a 64 Orphan Status 64 xanthine oxidase inhibitor 64 Pfizer Sutent 64 vorinostat 64 Taxotere ® 64 mTOR inhibitor 64 ZACTIMA 64 Carfilzomib 64 Ustekinumab 64 sorafenib Nexavar 64 Mipomersen 64 Camptosar ® 64 ZOLINZA 64 Fludarabine 64 Orphan Drug Status 64 Metastatic Colorectal Cancer 64 Etanercept 64 Maribavir 64 Saforis 64 Romiplostim 64 Alfimeprase 64 Clofarabine 64 Rilonacept 64 lumiliximab 64 sorafenib tablets 64 Docetaxel 64 pixantrone 64 pertuzumab 64 ixabepilone 63 Mitoxantrone 63 docetaxel Taxotere ® 63 Trastuzumab 63 Degarelix 63 Bafetinib 63 Ocrelizumab 63 OPAXIO 63 Gleevec imatinib mesylate 63 TREANDA 63 T DM1 63 Jevtana 63 nilotinib 63 azacitidine 63 Celgene Revlimid 63 Certican 63 Marketing Authorisation Application 63 Advagraf 63 Gleevec resistant 63 IL# PE#QQR 63 Eculizumab 63 Aflibercept 63 Evoltra 63 Actemra 63 Ambrisentan 63 metastatic malignant 63 tocilizumab 63 vemurafenib 63 Fast Track Status 63 Velcade bortezomib 63 Satraplatin 63 glufosfamide 63 Abatacept 63 anticancer therapy 63 topical NSAID 63 temsirolimus 63 efalizumab 63 Meets Primary Endpoint 63 etanercept Enbrel 63 HuMax EGFr 63 Gemzar ® 63 Pralatrexate 63 Fludara 63 Marketing Authorization Application 63 bendamustine 63 Oxaliplatin 63 Proxinium TM 63 Fodosine 63 Arzerra 63 Maraviroc 63 Marqibo 63 Bortezomib 63 MabCampath 63 TELINTRA 63 Xcytrin 63 ADVEXIN 63 Rivaroxaban 63 GW# [003] 63 Carboplatin 63 Panitumumab 63 dasatinib Sprycel ® 63 Valsartan 63 pomalidomide 63 AVASTIN 63 thalidomide Thalomid 63 sunitinib malate 62 EOquin TM 62 trastuzumab Herceptin 62 Clolar ® 62 erlotinib Tarceva ® 62 FASLODEX 62 Telavancin 62 Xanafide 62 Mepact 62 Arimoclomol 62 Dalbavancin 62 Voreloxin 62 Ciclesonide 62 phase IIb clinical 62 Vidaza azacitidine 62 lupus nephritis 62 Cimzia ® 62 abatacept Orencia 62 Tesetaxel 62 histone deacetylase HDAC inhibitor 62 FOLFIRI 62 Vidofludimus 62 Pixuvri 62 Bosutinib 62 Onconase 62 Genasense 62 MAGE A3 ASCI 62 Bendamustine 62 Taxol paclitaxel 62 orphan designation 62 UPLYSO 62 IMGN# 62 potentially hepatotoxic 62 Cloretazine ® 62 Lubiprostone 62 Erbitux cetuximab 62 Roche Actemra 62 lapatinib Tykerb 62 Natalizumab 62 REVLIMID R 62 Herceptin trastuzumab 62 Genasense ® 62 Trabectedin 62 eltrombopag 62 alefacept 62 TORISEL 62 mapatumumab 62 Fibrillex TM 62 malignant ascites 62 Zolinza 62 alvimopan 62 receptor tyrosine kinase inhibitor 62 Votrient 62 Ranibizumab 62 Radioimmunotherapy 62 INCB# [001] 62 refractory chronic lymphocytic 62 Hycamtin ® 62 Boceprevir 62 Tacrolimus 62 Actemra tocilizumab 62 Dacogen injection 62 Paraplatin ® 62 Fingolimod 62 Lacosamide 62 EOquin 62 Icatibant 62 SinuNase 62 relapsing multiple sclerosis 62 Topotecan 62 relapsed refractory 62 Halaven 62 Cytarabine 62 icatibant 62 Temsirolimus 62 Cloretazine 62 Tocilizumab 62 Pivotal Phase III 62 Alvesco R 62 BAL# [002] 62 Etravirine 62 DOXIL 62 TH# [003] 62 Folotyn 62 Catena ® 62 Omnitarg 62 Azedra 62 cetuximab Erbitux ® 62 Sutent sunitinib 61 Bosentan 61 Sapacitabine 61 Anastrozole 61 dasatinib Sprycel 61 oral prodrug 61 Fast Track Designation 61 Archexin 61 Ridaforolimus 61 KRN# 61 ZEVALIN ® 61 adalimumab Humira 61 romiplostim 61 tesmilifene 61 metastatic renal cell carcinoma 61 ONGLYZA ™ 61 Anti TNF 61 thymalfasin 61 ORENCIA R 61 Dabigatran etexilate 61 trabectedin 61 Pivotal Trial 61 Orphan Drug 61 Platinol ® 61 HER2 positive metastatic breast 61 Adjuvant Treatment 61 Increlex R 61 MyVax R 61 Microplasmin 61 NOXAFIL 61 Tipranavir 61 Infliximab 61 Zarnestra 61 Ixempra 61 Bayer Nexavar 61 Traficet EN 61 Orphan Designation 61 AMN# [001] 61 Yondelis ® 61 PROMACTA 61 TAXOTERE R 61 cabazitaxel 61 Cimzia TM 61 Novartis Afinitor 61 Dyloject TM 61 EndoTAG TM -1 61 VEGF inhibitor 61 TYKERB 61 Talabostat 61 Diovan HCT 61 FTY# 61 Romidepsin 61 cetuximab Erbitux 61 Novartis Gleevec 61 Gefitinib 61 Laquinimod 61 Vorinostat 61 EFAPROXYN 61 Neoadjuvant 61 Advanced Melanoma 61 VIDAZA 61 Campath 61 Specifid 61 dasatinib 61 Teriparatide 61 Telaprevir 61 SUTENT 61 clofarabine 61 mRCC 61 gastrointestinal stromal tumors GIST 61 bortezomib Velcade 61 mertansine 61 HuMax CD4 61 Tezampanel 61 IRESSA 61 Dabigatran 61 Navelbine ® 61 Lapatinib 61 Procoralan 61 Tarceva TM 61 azacytidine 61 rituximab Rituxan 61 acute HAE attacks 61 bevacizumab Avastin ® 61 HoFH 61 Ganciclovir 61 DepoDur 61 Safinamide 61 Targretin capsules 61 sargramostim 61 combretastatin A4 phosphate CA4P 61 Arranon 61 Phase III Clinical Trial 61 Doxorubicin 61 Taxotere docetaxel 61 Tanespimycin 61 glatiramer 61 Cladribine 61 novel oral anticoagulant 61 Fludara ® 61 gemcitabine Gemzar 61 BRAF inhibitor 61 Ceflatonin R 61 proteasome inhibitor 61 panitumumab Vectibix 61 generation purine nucleoside 61 rilonacept 61 ACZ# 61 Orazol 61 Rasagiline 61 TAXOTERE ® 61 calcineurin inhibitors 61 tanespimycin 61 oral ridaforolimus 61 Nilotinib 61 REVLIMID 61 Muraglitazar 60 Troxatyl 60 carfilzomib 60 Aplidin 60 Cetuximab 60 baminercept 60 fluoropyrimidine 60 Ranolazine 60 Gliadel Wafer 60 Mylotarg 60 Cutaneous T 60 Onrigin 60 Fibrin Pad 60 relapsed ovarian cancer 60 SPRYCEL ® 60 Roflumilast 60 Gleevec Glivec 60 imatinib Gleevec ® 60 invasive candidiasis 60 Orphan Drug status 60 Kepivance 60 Ceflatonin ® 60 RAPAFLO 60 MabThera 60 Darunavir 60 Aliskiren 60 Pioglitazone 60 Darusentan 60 Raptiva ® 60 Neulasta ® 60 Ticagrelor 60 Imiquimod 60 AA amyloidosis 60 DOXIL ® 60 cutaneous T cell 60 regorafenib 60 oral anticoagulant 60 Accelerated Approval 60 Phase III Trial 60 Denosumab 60 Cimzia ® certolizumab pegol 60 refractory Hodgkin lymphoma 60 B CLL 60 Daclizumab 60 Fondaparinux 60 Nimotuzumab 60 Cimzia R 60 metastatic hormone refractory 60 BRIM2 60 Campath alemtuzumab 60 Neupogen ® 60 Bayer Onyx 60 SUTENT ® 60 pemetrexed Alimta 60 XYOTAX TM 60 investigational monoclonal antibody 60 Belimumab 60 interferon beta 1b 60 ZD# [001] 60 cangrelor 60 Nexavar sorafenib 60 docetaxel Taxotere 60 Evoltra TM 60 Orphan Drug Designation 60 Methylnaltrexone 60 riociguat 60 leukemia CLL 60 tigecycline 60 methylnaltrexone 60 Omalizumab 60 acyclovir Lauriad R 60 systemic immunosuppressive drugs 60 ZEVALIN 60 investigational humanized monoclonal antibody 60 Roche Xeloda 60 ZYVOX 60 Rifaximin 60 Pegloticase 60 mycophenolate mofetil 60 Diffuse Large B 60 CoFactor 60 Campath ® 60 Taxotere R 60 TRISENOX 60 RoACTEMRA 60 NDA Submission 60 Eltrombopag 60 Omacetaxine 60 Telmisartan 60 Cabazitaxel 60 chronic lymphocytic leukemia CLL 60 targeted radiotherapeutic 60 Xeloda ® 60 imatinib Gleevec 60 recurrent NSCLC 60 Interferon alfa 60 Zenvia Phase III 60 plasma kallikrein inhibitor 60 Ixabepilone 60 Crizotinib 60 IRX 2 60 orphan medicinal product 60 teriflunomide 60 EVIZON TM 60 romidepsin 60 VEGF Trap 60 non metastatic osteosarcoma 60 Soft Tissue Sarcoma 60 T#I [002] 60 radiation sensitizer 60 gefitinib Iressa 60 iniparib 60 Ventavis 60 Improved Survival 60 Fulvestrant 60 enzastaurin 60 tyrosine kinase inhibitor 60 Factor VIIa 60 relapsed refractory multiple myeloma 60 MabThera Rituxan 60 TNF Tumor Necrosis Factor 60 Melphalan 60 Glybera R 60 Teysuno 60 ganetespib 60 Orphan Drug designations 60 ImClone Erbitux 60 Celebrex celecoxib 60 SNT MC# 60 Panzem 60 Tasimelteon 60 depsipeptide 60 Rituxan 60 PEGylated Fab fragment 60 Ceftobiprole 60 Filgrastim 60 ofatumumab 60 ALGRX 60 Toxicities 60 MEK inhibitors 60 AQ4N 60 galiximab 60 Tolvaptan 60 JAK inhibitor 60 anti angiogenic agent 60 ADP receptor antagonist 60 ruxolitinib 60 superficial bladder cancer 60 acyclovir Lauriad ® 60 Combidex 59 Peginterferon alfa 2b 59 Junovan 59 RhuDex ® 59 microtubule inhibitor 59 IMiDs 59 Friedreich Ataxia FRDA 59 APTIVUS R 59 Panzem R NCD 59 anti EGFR antibody 59 IMC A# 59 lomitapide 59 Hormone Refractory Prostate Cancer 59 proteasome inhibitor bortezomib 59 immunotherapeutic agent 59 Certolizumab pegol 59 pain palliation 59 Dronedarone 59 Azathioprine 59 Bezielle 59 Pyridorin 59 chemotherapeutic regimen 59 docetaxel Taxotere R 59 Apixaban 59 Ilaris 59 posaconazole 59 COPAXONE ® 59 Neurodex 59 Dacogen decitabine 59 Toctino ® alitretinoin 59 SomatoKine 59 lymphoma CTCL 59 Vidaza 59 MGd 59 Squalamine 59 FDA Orphan Drug 59 PDE4 inhibitor 59 infusional 5-FU/LV 59 Betaferon ® 59 Tamibarotene 59 AZILECT R 59 Genasense R 59 tafamidis 59 Promacta 59 IV Busulfex 59 hA# 59 Emselex 59 Silodosin 59 Lenocta 59 Paclitaxel 59 Glioblastoma Multiforme 59 VALSTAR 59 Arcalyst 59 acute GvHD 59 dextromethorphan quinidine 59 anti angiogenic agents 59 somatostatin analogues 59 MYCAMINE 59 palliative radiotherapy 59 Novantrone 59 multi kinase inhibitor 59 cinacalcet 59 Onsolis 59 Actimmune ® 59 Nuedexta 59 AZILECT ® 59 Phase #b/#a clinical 59 paclitaxel Taxol 59 relapsing remitting multiple sclerosis 59 Allovectin 7 ® 59 Pfizer Lyrica 59 HQK 59 abiraterone acetate 59 dopamine partial agonist 59 Apaziquone 59 Pulmonary Arterial Hypertension 59 Cimzia 59 Tarceva erlotinib 59 #D#C# 59 Relapsing Remitting Multiple Sclerosis 59 Hsp# Inhibitor 59 TG# [003] 59 Arzerra ofatumumab 59 Sprycel dasatinib 59 Octreolin 59 Voraxaze 59 Thalomid ® 59 diabetic neuropathic pain 59 Eribulin 59 multiple myeloma MM 59 INTELENCE 59 Riquent 59 rNAPc2 59 efaproxiral 59 cell lymphoma CTCL 59 Tygacil 59 Removab 59 galantamine 59 malignant pleural mesothelioma 59 Annamycin 59 erlotinib Tarceva 59 cetuximab Erbitux R 59 Combination REOLYSIN R 59 gemcitabine chemotherapy 59 Oral Mucositis 59 Azixa 59 Febuxostat 59 antimetabolite 59 Riluzole 59 Vectibix 59 Atacand 59 gemcitabine carboplatin 59 Indaflex TM 59 Gleevec imatinib 59 tipranavir 59 Tekamlo 59 pseudobulbar affect PBA 59 Anthracycline 59 Teriflunomide 59 oropharyngeal candidiasis 59 Cloretazine R VNP#M 59 Ceplene 59 Follicular Lymphoma 59 RoActemra 59 standard chemotherapy regimen 59 Aptivus ® 59 Diabetic Macular Edema 59 Atrasentan 59 vismodegib 59 AP# [003] 59 octreotide implant 59 Eraxis 59 PEG SN# 59 OncoVEX GM CSF 59 Betaferon R 59 Liprotamase 59 CANCIDAS 59 Aviptadil 59 Ceplene/IL-2 59 ASA# 59 Orphan Drug designation 59 chemotherapeutic agent 59 cladribine 59 refractory NSCLC 59 pegylated interferons 59 Vion Pharmaceuticals 59 Vfend 59 immunomodulator 59 Azacitidine 59 vidofludimus 59 Granisetron 59 docetaxel chemotherapy 59 Afatinib 59 Taxotere chemotherapy 59 Onbrez Breezhaler 59 myelofibrosis polycythemia vera 59 Advanced Renal Cell 59 cisplatin chemotherapy 59 pegfilgrastim 59 Phase IIIb clinical 59 Avanafil 59 oxaliplatin Eloxatin 59 zalutumumab 59 beta 1a 59 rALLy 59 Increlex ® 59 Pivotal Study 59 DU #b 59 Bevacizumab Avastin 59 Enzyme Replacement Therapy 59 CDP# 59 visilizumab 59 Phase IIb Trial 59 carboplatin paclitaxel 59 Omapro 59 myelodysplastic syndrome MDS 59 recurrent GBM 59 RSR# 59 aflibercept 59 SCCHN 59 LEUKINE 59 elacytarabine 59 chronic myeloid leukemia CML 59 Elagolix 59 Abiraterone acetate 59 relapsed MM 59 Imatinib 59 BEXXAR 59 PSMA ADC 59 Chemophase 59 aflibercept VEGF Trap 59 FIRAZYR 59 Dupuytren Contracture 59 UCB Cimzia 59 AstraZeneca Symbicort 59 STELARA TM 59 corticosteroid dexamethasone 59 anticancer agent 59 Myelofibrosis 59 pegylated liposomal doxorubicin 59 IMA# 59 fenretinide 59 Orphan Medicinal Product 59 TYZEKA 59 MyVax 59 Valopicitabine 59 cyclophosphamide doxorubicin vincristine 59 vinorelbine 59 palifermin 59 miconazole Lauriad R 59 Civacir 59 R sorafenib tablets 59 PEGINTRON TM 59 Leukine 59 MNTX 59 sorafenib Nexavar ® 59 Granulocyte Colony Stimulating Factor 59 Ceftaroline 59 noninfectious uveitis 59 elotuzumab 59 Sym# 59 Axitinib 59 Fluorouracil 58 Cladribine Tablets 58 ELND# 58 VAPRISOL 58 PRIALT 58 PLK1 SNALP 58 HDAC Inhibitor 58 Cyclophosphamide 58 Lupus Nephritis 58 Hexvix ® 58 Vidaza R 58 Temozolomide 58 Initiate Clinical Trial 58 ACTEMRA 58 chlorambucil 58 REVLIMID ® 58 PNP inhibitor 58 Granted Orphan Drug 58 Aryplase 58 unique alkylating agent 58 subcutaneous formulation 58 Treatment Regimen 58 orBec 58 Myelodysplastic Syndrome MDS 58 Personalized Immunotherapy 58 RG# [001] 58 Doxil ® 58 Abacavir 58 Zenpep 58 Phase Ib study 58 topical ophthalmic 58 Clolar 58 AMEVIVE 58 Zybrestat 58 systemic fungal infections 58 BEMA TM Fentanyl 58 Carvedilol 58 Zorbtive TM 58 previously untreated follicular 58 Alferon N 58 ularitide 58 bosutinib 58 Decitabine 58 Phenoptin 58 Arixtra 58 Renal Cell Carcinoma 58 Glatiramer Acetate 58 Abraxane 58 Antitumor Activity 58 APTIVUS 58 cediranib 58 ranolazine 58 liposomal formulation 58 forodesine 58 Evoltra ® 58 Patient Enrollment 58 Trobalt 58 dual endothelin receptor antagonist 58 Allovectin 7 58 Exemestane 58 ThermoDox ® 58 StaphVAX 58 EGS# 58 fosbretabulin 58 Newly Diagnosed Multiple Myeloma 58 gemtuzumab ozogamicin 58 RhuDex 58 Glufosfamide 58 DMXAA 58 metaglidasen 58 Ecallantide 58 Moxifloxacin 58 ALVESCO R 58 PROCHYMAL 58 RAPTIVA 58 multitargeted 58 CIMZIA ™ 58 Virulizin ® 58 Revlimid 58 Xelox 58 HuMax CD# 58 ATL# [001] 58 gastrointestinal stromal tumor GIST 58 Xeloda capecitabine 58 gastrointestinal stromal tumors 58 Pegylated Liposomal Doxorubicin 58 Myelodysplastic Syndrome 58 reslizumab 58 Rheumatoid Arthritis RA 58 lapatinib 58 Myelodysplastic Syndromes 58 refractory AML 58 Blinatumomab 58 Leukine ® 58 Interferon alpha 58 ACAPODENE 58 veltuzumab 58 Chronic Myeloid Leukemia 58 BANZEL 58 refractory CLL 58 ATIR 58 Drug Candidate 58 Octreotide 58 Li Fraumeni Syndrome 58 Panzem R 58 targeted antifolate 58 Lilly Gemzar 58 antiplatelet agent 58 Androxal TM 58 Protelos 58 Lomitapide 58 leukotriene receptor antagonist 58 Monotherapy 58 tipifarnib 58 Chronic Lymphocytic Leukemia CLL 58 MoxDuo IR 58 Sanofi Aventis Taxotere 58 Elitek 58 ONCASPAR 58 CEQ# 58 paclitaxel Taxol ® 58 Radiofrequency Ablation RFA 58 Metastatic breast cancer 58 proteasome inhibitors 58 AeroLEF TM 58 basiliximab 58 rasagiline tablets 58 XGEVA 58 PEG INTRON 58 Zelrix 58 Alitretinoin 58 CLL 58 cilengitide 58 Sandostatin LAR 58 OMP designation 58 Certolizumab 58 Abbott Humira 58 MEPACT 58 echinocandin 58 amrubicin 58 INCB# [002] 58 TNF alpha inhibitor 58 Vimpat R 58 Zoledronic acid 58 CINTREDEKIN BESUDOTOX 58 Targretin 58 Anidulafungin 58 Amplimexon 58 CD# monoclonal antibody 58 oral mucositis 58 obatoclax 58 autologous cellular immunotherapy 58 thetreatment 58 MOZOBIL 58 bortezomib Velcade R 58 lexidronam injection 58 anticancer compound 58 mitomycin 58 metastatic castration resistant 58 Neuvenge 58 angiogenesis inhibitor 58 Tesmilifene 58 rotigotine transdermal patch 58 Investigational Treatment 58 raloxifene Evista 58 relapsed leukemia 58 Oral Spray 58 MGCD# [001] 58 RH1 58 Raptiva R 58 anthracycline derivative 58 GvHD 58 Synvisc One 58 Investigational Agent 58 Pradefovir 58 relapsed multiple myeloma 58 REMINYL ® 58 Vicinium TM 58 ALN TTR 58 sunitinib Sutent ® 58 octreotide acetate 58 schizophrenia CIAS 58 Disease Progression 58 Zingo TM 58 Carbaglu 58 lenalidomide Revlimid R 58 tasocitinib 58 Evicel 58 TELCYTA 58 Abbott HUMIRA 58 Non Hodgkin 58 AEG# 58 PROCRIT 58 Aurexis 58 TheraCIM 58 PrevOnco 58 idebenone 58 BLP# Liposome Vaccine 58 Entereg 58 ISENTRESS 58 Ramelteon 58 Chronic Lymphocytic Leukemia 58 Levoleucovorin 58 Sanvar R 58 Darinaparsin 58 Surgical resection 58 OMAPRO ™ 58 dosage regimens 58 CIMZIA TM 58 Immunosuppressant 58 Complete Response 58 PLX# 58 follicular NHL 58 luteinizing hormone releasing 58 peginterferon alfa 58 interferon therapy 58 terlipressin 58 Tyrosine Kinase Inhibitor 58 oblimersen 58 platinum refractory 58 severe gastroparesis 58 Survival Benefit 58 oral iron chelator 58 Soliris eculizumab 58 ISTODAX 58 SJIA 58 Saxagliptin 58 BiovaxID 58 fingolimod 58 ARIXTRA R 58 Virulizin R 58 dacetuzumab 58 Bicifadine 58 Afinitor ® 58 CAELYX 58 Extavia 58 TBC# 58 Pivotal Phase 58 FOLOTYN ® 58 abatacept 58 subependymal giant cell 58 mild vasodilator 58 canakinumab 58 CIMZIA TM certolizumab pegol 58 cytotoxic chemotherapy 58 Northera 58 EGFR TKI 58 Zortress 58 ZACTIMA TM ZD# 58 opioid induced bowel dysfunction 58 infliximab Remicade 58 Brentuximab Vedotin SGN 58 Vicriviroc 58 THALOMID 58 FDA Accepts 58 Eloxatin 58 paclitaxel poliglumex 58 FOLFOX chemotherapy 58 immunosuppressant 58 AVONEX ® 58 QVAR ® 58 Lamotrigine 58 daptomycin 58 PEGylated interferon beta 1a 58 BENLYSTA ® 58 Fusilev 58 Kynapid 58 metastatic kidney 58 Prolongs Survival 58 TEMODAR 58 lurasidone 58 #ME# 57 myelodysplastic syndromes 57 Sprycel 57 Milnacipran 57 Sutent 57 DACH platinum 57 HYCAMTIN 57 Bronchitol 57 trastuzumab DM1 57 Ibritumomab Tiuxetan 57 boosted protease inhibitor 57 BYETTA ® 57 VPRIV 57 CD# antibody [001]